These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. Kilbourne ED, Cerini CP, Khan MW, Mitchell JW, Ogra PL. J Immunol; 1987 May 01; 138(9):3010-3. PubMed ID: 3571981 [Abstract] [Full Text] [Related]
10. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. J Infect Dis; 2015 Oct 15; 212(8):1191-9. PubMed ID: 25858957 [Abstract] [Full Text] [Related]
11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M. J Infect Dis; 1999 May 15; 179(5):1132-8. PubMed ID: 10191214 [Abstract] [Full Text] [Related]
12. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Johansson BE, Kilbourne ED. Virology; 1996 Nov 01; 225(1):136-44. PubMed ID: 8918540 [Abstract] [Full Text] [Related]
14. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep 01; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
20. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. Patel A, Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP. Vaccine; 2009 May 18; 27(23):3083-9. PubMed ID: 19428922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]